palbociclib: single-agent or in combination for the treatment of breast cancer
Published 6 years ago • 273 plays • Length 6:47Download video MP4
Download video MP3
Similar videos
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:29
breast cancer: palbociclib in later lines
-
7:27
polaris: palbociclib for bipoc patients with her2-negative breast cancer
-
3:03
integrating palbociclib into the treatment of breast cancer
-
1:56
vepdegestrant palbociclib in er metastatic breast cancer: phase ib trial results
-
5:34
engot-en3-nsgo/paleo: letrozole-palbociclib combination for endometrial cancer
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
4:40
ameera-1 updates: amcenestrant plus palbociclib for patients with er /her2– advanced breast cancer
-
13:22
palbociclib and breast cancer
-
1:49
palbociclib combo therapies for advanced breast cancer
-
13:24
palbociclib combinations on treatment of advanced breast cancer – video abstract [id 77033]